Psychiatrists for Depression Near Washington, DC
· Updated November 2026 · Aazaz Haq, MD
Many of the people who come to see us live or work in Washington, DC. Most have already seen a doctor for depression, tried more than one medication, and are tired of starting over. If that sounds familiar, here is what we do and how we approach it.
The short answer
McLean NTC is a psychiatrist-led clinic in McLean, Virginia, a short drive from Washington, DC, focused on depression that has not responded to standard treatment. We start with a careful evaluation and offer TMS, esketamine, IV and IM ketamine, VNS management and medication management, with most major insurance plans accepted.
Who we are
McLean Neuropsychiatric Treatment Center is a psychiatrist-led clinic in McLean, Virginia, a short drive across the Potomac from the District. We focus on depression that has not improved enough with standard treatment, along with OCD and related conditions. I founded the clinic and serve as its medical director. I am board-certified in adult and geriatric psychiatry, and our team includes psychiatrists and advanced practice clinicians. We are also a clinical training site for Georgetown University psychiatry residents.
We start with the evaluation
When depression has not improved, the next step is to ask better questions before choosing a treatment. Your first visit with a clinician reviews:
- The diagnosis. Bipolar depression, trauma, grief, sleep problems, medical illness and substance use can all make depression harder to treat.
- What you have tried, at what dose, for how long, and why it stopped.
- How you are functioning: work, family, self-care.
- Safety.
Many people labeled treatment-resistant were never on the right dose for long enough, or have a condition that was missed. That review comes first.
Treatments we provide
- TMS: FDA-cleared magnetic stimulation. No anesthesia, and you drive yourself home.
- Esketamine (Spravato): FDA-approved nasal spray, given in our certified clinic with two hours of monitoring.
- Ketamine by IV or IM injection: in a monitored setting, for carefully selected patients.
- TMS for OCD.
- VNS management for patients with an implanted stimulator.
- Medication management, often alongside these treatments.
We do not perform ECT. When it is the right option, we refer you to a program that provides it.
Insurance and access
We accept Medicare, Virginia Medicaid, CareFirst BlueCross BlueShield, Tricare and most major commercial plans; the full list is on our insurance page. Our team checks your benefits and tells you your expected costs before you start.
Getting started
The first step is a free consultation call with our patient advocate, who will help you decide whether a psychiatric evaluation is right for you. Nothing about that call commits you to treatment. Request a consultation call.
Questions I hear often
Do you accept DC residents?
Yes. Many of our patients live in the District. Our clinicians are licensed in Virginia, where treatment takes place.
How soon can I be seen?
Our patient advocate calls you back within one business day. Evaluation timing depends on your insurance and schedule, and we work to keep the wait short.
Can my DC therapist or psychiatrist stay involved?
Absolutely. We coordinate with your existing clinicians, with your permission, and send updates after the evaluation and at key points in treatment.
What we ask you to bring
- Your insurance card.
- A list of medications you take now and have tried before, with doses and how long you took each, if you know them.
- Names of your current clinicians.
- Any questions you want answered. We would rather you ask than wonder.
For clinicians in DC
If you are referring a patient, our referrals page explains the process. My guides for colleagues, The Stuck Patient for therapists and When Depression Treatment Stalls for medical clinicians, describe how we think about these cases.
References
- Rush AJ, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006. PubMed
- Carpenter LL, et al. TMS for major depression: a multisite, naturalistic, observational study. Depress Anxiety. 2012. PubMed
- Popova V, et al. Esketamine nasal spray in treatment-resistant depression (TRANSFORM-2). Am J Psychiatry. 2019. PubMed